| Rabeprazole Krka 10mg Gastro-Resistant Tablets PA1347/030/001 |
Rabeprazole sodium |
KRKA, d.d., Novo mesto |
Marketed |
| Rabeprazole Krka 20mg Gastro-Resistant Tablets PA1347/030/002 |
Rabeprazole sodium |
KRKA, d.d., Novo mesto |
Marketed |
| Raener 2 mg/0.03 mg film-coated tablets PA1474/011/001 |
Dienogest micronized, Ethinylestradiol micronized |
Laboratorios Leon Farma, S.A. |
Not marketed |
| Raloxifene Teva 60 mg film-coated tablets EU/1/10/627/1-3 |
Raloxifene hydrochloride |
Teva B.V. |
— |
| Ramilo 1.25 mg tablets PA0711/063/001 |
Ramipril |
Rowex Limited, |
Marketed |
| Ramilo 10 mg Tablets PA0711/063/004 |
Ramipril |
Rowex Limited, |
Marketed |
| Ramilo 2.5 mg tablets PA0711/063/002 |
Ramipril |
Rowex Limited, |
Marketed |
| Ramilo 5 mg tablets PA0711/063/003 |
Ramipril |
Rowex Limited, |
Marketed |
| Ramipril Krka 1.25 mg tablets PA1347/042/001 |
Ramipril |
KRKA, d.d., Novo mesto |
Marketed |
| Ramipril Krka 10 mg tablets PA1347/042/004 |
Ramipril |
KRKA, d.d., Novo mesto |
Marketed |
| Ramipril Krka 2.5 mg tablets PA1347/042/002 |
Ramipril |
KRKA, d.d., Novo mesto |
Marketed |
| Ramipril Krka 5 mg tablets PA1347/042/003 |
Ramipril |
KRKA, d.d., Novo mesto |
Marketed |
| Ramipril Teva Pharma 1.25mg Tablets PA0749/177/001 |
Ramipril |
Teva Pharma B.V. |
Marketed |
| Ramipril Teva Pharma 10mg Tablets PA0749/177/004 |
Ramipril |
Teva Pharma B.V. |
Marketed |
| Ramipril Teva Pharma 2.5mg Tablets PA0749/177/002 |
Ramipril |
Teva Pharma B.V. |
Marketed |
| Ramipril Teva Pharma 5mg Tablets PA0749/177/003 |
Ramipril |
Teva Pharma B.V. |
Marketed |
| Ramitace 10mg Tablets PA0126/163/003 |
Ramipril |
Clonmel Healthcare Ltd |
Marketed |
| Ramitace 2.5mg Tablets PA0126/163/001 |
Ramipril |
Clonmel Healthcare Ltd |
Marketed |
| Ramitace 5 mg tablets PA0126/163/002 |
Ramipril |
Clonmel Healthcare Ltd |
Marketed |
| Ramonna 1500 microgram Tablet PA1330/021/001 |
Levonorgestrel |
Gedeon Richter Plc |
Marketed |
| Ranexa 375 mg prolonged-release tablets EU/1/08/462/1,2,7,8 |
Ranolazine |
Menarini International Operations Luxembourg S.A. |
— |
| Ranexa 500 mg prolonged-release tablets EU/1/08/462/3,4,9,10 |
Ranolazine |
Menarini International Operations Luxembourg S.A. |
— |
| Ranexa 750 mg prolonged-release tablets EU/1/08/462/5,6,11,12 |
Ranolazine |
Menarini International Operations Luxembourg S.A. |
— |
| Ranivisio 10 mg/ml solution for injection EU/1/22/1673/001 |
Ranibizumab |
Midas Pharma GmbH |
— |
| Ranolazine Accord 375 mg prolonged-release tablets PA2315/259/001 |
Ranolazine |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Ranolazine Accord 500 mg prolonged-release tablet PA2315/259/002 |
Ranolazine |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Ranolazine Accord 750 mg prolonged-release tablets PA2315/259/003 |
Ranolazine |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Ranolazine Clonmel 375 mg prolonged-release tablets PA0126/356/001 |
Ranolazine |
Clonmel Healthcare Ltd |
Marketed |
| Ranolazine Clonmel 500 mg prolonged-release tablets PA0126/356/002 |
Ranolazine |
Clonmel Healthcare Ltd |
Marketed |
| Ranolazine Clonmel 750 mg prolonged-release tablets PA0126/356/003 |
Ranolazine |
Clonmel Healthcare Ltd |
Marketed |
| Ranolazine Krka 375 mg prolonged-release tablets PA1347/109/001 |
Ranolazine |
KRKA, d.d., Novo mesto |
Marketed |
| Ranolazine Krka 500 mg prolonged-release tablets PA1347/109/002 |
Ranolazine |
KRKA, d.d., Novo mesto |
Marketed |
| Ranolazine Krka 750 mg prolonged-release tablets PA1347/109/003 |
Ranolazine |
KRKA, d.d., Novo mesto |
Marketed |
| Rapamune EU/1/01/171/14 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 0.5 mg Coated tablet EU/1/01/171/013-014 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 1 mg Coated tablet EU/1/01/171/007 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 1 mg Coated tablet EU/1/01/171/008 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 1 mg/ml Oral solution EU/1/01/171/001 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 2 mg Coated tablet EU/1/01/171/009-010 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapibloc 300 mg powder for solution for infusion PA1353/007/001 |
Landiolol hydrochloride |
Orpha-Devel Handels und Vertriebs GmbH |
Marketed |
| Rapifen 500 micrograms/ml solution for injection or infusion PA22583/001/001 |
ALFENTANIL HYDROCHLORIDE |
Piramal Critical Care B.V. |
Not marketed |
| Rapilysin 10 U powder and solvent for solution for injection. EU/1/96/018/001 |
Reteplase |
Actavis Group hf |
— |
| Rapiscan 400 microgram solution for injection EU/1/10/643/001 |
Regadenoson |
GE Healthcare AS |
— |
| Raporsin 4 mg prolonged-release tablets PA2315/005/002 |
Doxazosin mesilate |
Accord Healthcare Ireland Ltd. |
Marketed |
| Raporsin 8 mg prolonged-release tablets PA2315/005/001 |
Doxazosin |
Accord Healthcare Ireland Ltd. |
Marketed |
| Rasagiline Accord 1 mg tablets PA2315/174/001 |
Rasagiline |
Accord Healthcare Ireland Ltd. |
Marketed |
| Rasagiline Clonmel 1 mg tablets PA0126/276/001 |
Rasagiline |
Clonmel Healthcare Ltd |
Marketed |
| Rasagiline Krka 1 mg tablets PA1347/088/001 |
Rasagiline |
KRKA, d.d., Novo mesto |
Marketed |
| Rasagiline Mylan 1 mg tablets EU/1/16/1090/001-012 |
Rasagiline |
Viatris Limited |
— |
| Rasagiline Ratiopharm 1 mg tablets EU/1/14/977/001-007 |
Rasagiline |
Teva B.V. |
— |